AC Immune SA (ACIU) News

Latest headlines that mention ACIU, newest first · each headline opens the original publisher

ACIU quote

Last price: $2.26
Day change: -1.31%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

ACIU headlines

latest coverage

Investing.com 6d ago

AC Immune earnings beat by CHF0.03, revenue topped estimates

Earnings T3ACIU

Seeking Alpha 7d ago

AC Immune GAAP EPS of -CHF0.13, revenue of CHF3.24M

Earnings T2ACIU

Seeking Alpha News 1mo ago

AC Immune: Buy Continued ACI-7104 Progress, PD, And Pipeline Expansions

General T2ACIU

Seeking Alpha 1mo ago

AC Immune spikes after mid-stage trial data for Parkinson’s drug

General T2ACIU

Investing.com 1mo ago

AC Immune reports positive phase 2 trial results for ACI-7104

General T3ACIU

Investing.com 2mo ago

AC Immune stock rating reiterated at Buy by H.C. Wainwright

General T3ACIU

Seeking Alpha 2mo ago

AC Immune gains on early-stage trial data for anti-inflammatory agent

General T2ACIU

Investing.com 2mo ago

AC Immune reports phase 1 safety data for NLRP3 inhibitor

General T3ACIU

Seeking Alpha 3mo ago

AC Immune reports 1H results

General T2ACIU

Seeking Alpha News 4mo ago

AC Immune: Holding Into A Make-Or-Break H2 2026 Readout

General T2ACIU

Seeking Alpha 6mo ago

AC Immune CEO Andrea Pfeifer to retire after 23 years

General T2ACIU

ACIU news alerts

Get an alert by email or push when a new headline mentions ACIU.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.